Voyageur Announces Year-End Audited Financial Statements & MD&A

2020-04-04 / @thenewswire

 

(TheNewswire)



CALGARY, Alberta – TheNewswire- April 3rd,2020 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the “Company” or “Voyageur”) (formally Voyageur Minerals Ltd.) is pleased to announce the filing of its 2019 year-end audited Financial Statements and MD&A. The Company's Financial Statements and MD&A are available on SEDAR (www.sedar.com).

About Voyageur

Voyageur Pharmaceuticals Ltd. is Canadian public company listed on the TSX Venture Exchange under the trading symbol VM. Voyageur is focused on the development of barite and iodine Active Pharmaceutical Ingredient (API) minerals. The near-term focus is developing barium and iodine radiocontrast products and bromine based pharmaceutical products.  

Voyageur owns a 100% interest in three barium sulfate (barite) deposits including two properties suitable in grade for the industrial barite marketplace, including interests in a high-grade iodine, lithium & bromine brine project in Utah, USA.

For further information, please contact:

Steven R. Livingston
Cell: (403) 471-1659
Office: (587)-779-6166
steve@vpharma.ca
www.voyageurpharmaceuticals.ca

Reader Advisory

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

Cautionary Note Regarding Forward-Looking Statements

This news release contains certain statements or disclosures relating to the Company that are based on the expectations of its management as well as assumptions made by and information currently available to the Company which may constitute forward-looking statements or information ("forward-looking statements") under applicable securities laws. All such statements and disclosures, other than those of historical fact, which address activities, events, outcomes, results or developments that the Company anticipates may or will occur in the future (in whole or in part) should be considered forward-looking statement and undue reliance should not be placed on any such statements. In some cases, forward-looking statements can be identified by the use of the words "will", "intends", “believes”, “expects”, forecasts”, "anticipates", "plans" and similar expressions.

In particular, but without limiting the foregoing, this news release contains forward-looking statements regarding its ability to file its Financial Statements and MD&A for the year ended November 30, 2019 [NTD: and its ability to preserve capital under the market conditions triggered by the COVID-19 pandemic]. The forward-looking statements contained in this news release are made as of the date hereof and the Company undertakes no obligations to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. Forward-looking information is not, and cannot be, a guarantee of future results or events. Forward-looking information is based on, among other things, opinions, assumptions, estimates and analyses that, while considered reasonable by Voyageur at the date the forward-looking information is provided, inherently are subject to significant risks, uncertainties, contingencies and other factors that may cause actual results and events to be materially different from those expressed or implied by the forward-looking information. The material factors or assumptions that Voyageur identified and were applied by Voyageur in drawing conclusions or making forecasts or projections set out in the forward-looking information include, but are not limited to, the ability of the Company to file its Financial Statements and MD&A for the year ended November 30, 2019 [NTD: and to preserve capital under the market conditions] triggered by the COVID-19 pandemic

The risks, uncertainties, contingencies and other factors that may cause actual results to differ materially from those expressed or implied by the forward-looking information may include, but are not limited to, risks associated with the COVID-19 coronavirus, as well as the risks discussed under the heading “Risk Factors” in Voyageur most recent interim Management Discussion and Analysis dated October 30, 2019.

Should one or more risk, uncertainty, contingency or other factor materialize or should any factor or assumption prove incorrect, actual results could vary materially from those expressed or implied in the forward-looking information. Accordingly, readers should not place undue reliance on forward-looking information. Voyageur does not assume any obligation to update or revise any forward-looking information after the date of this news release or to explain any material difference between subsequent actual events and any forward-looking information, except as required by applicable law.

Copyright (c) 2020 TheNewswire - All rights reserved.